ArticleOncotarget2020

Advances in meningioma genomics, proteomics, and epigenetics: insights into biomarker identification and targeted therapies.

Ahmad A Nazem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.